About this Journal Submit a Manuscript Table of Contents
Journal of Aging Research
Volume 2013 (2013), Article ID 734509, 11 pages
http://dx.doi.org/10.1155/2013/734509
Review Article

Impact of Endothelial Microparticles on Coagulation, Inflammation, and Angiogenesis in Age-Related Vascular Diseases

1Division of Rheumatology and Immunology, Medical University of South Carolina, 114 Doughty Street, STB, Charleston, SC 29425, USA
2Department of Biology, College of Charleston, Rita Liddy Hollings Science Center, Charleston, SC 29424, USA
3Department of Radiology, Maimonides Medical Center, Brooklyn, NY 11219, USA

Received 1 April 2013; Accepted 4 September 2013

Academic Editor: Barbara Shukitt-Hale

Copyright © 2013 Margaret Markiewicz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Liu, N. Reinmuth, O. Stoeltzing et al., “Antiangiogenic therapy targeting factors that enhance endothelial cell survival,” Seminars in Oncology, vol. 29, no. 3, pp. 96–103, 2002. View at Scopus
  2. D. H. Endemann and E. L. Schiffrin, “Endothelial dysfunction,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 1983–1992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Burger, A. C. Montezano, N. Nishigaki, Y. He, A. Carter, and R. M. Touyz, “Endothelial microparticle formation by angiotensin II is mediated via ang II receptor type I/NADPH Oxidase/rho kinase pathways targeted to lipid rafts,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 8, pp. 1898–1907, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Leroyer, F. Anfosso, R. Lacroix et al., “Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Owens and N. MacKman, “Microparticles in hemostasis and thrombosis,” Circulation Research, vol. 108, no. 10, pp. 1284–1297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Boulanger, “Microparticles, vascular function and hypertension,” Current Opinion in Nephrology and Hypertension, vol. 19, no. 2, pp. 177–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Boulanger and F. Dignat-George, “Microparticles: an introduction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 2–3, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. J. Moulin, D. Mayrand, H. Messier, M. C. Martinez, C. A. Lopez-Vallé, and H. Genest, “Shedding of microparticles by myofibroblasts as mediator of cellular cross-talk during normal wound healing,” Journal of Cellular Physiology, vol. 225, no. 3, pp. 734–740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Wolf, “The nature and significance of platelet products in human plasma,” The British Journal of Haematology, vol. 13, no. 3, pp. 269–288, 1967. View at Scopus
  10. R. J. Berckmans, R. Nieuwland, A. N. Böing, F. P. H. T. M. Romijn, C. E. Hack, and A. Sturk, “Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation,” Thrombosis and Haemostasis, vol. 85, no. 4, pp. 639–646, 2001. View at Scopus
  11. A. S. Leroyer, H. Isobe, G. Lesèche et al., “Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques,” Journal of the American College of Cardiology, vol. 49, no. 7, pp. 772–777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Meziani, A. Tesse, and R. Andriantsitohaina, “Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases,” Pharmacological Reports, vol. 60, no. 1, pp. 75–84, 2008. View at Scopus
  13. G. N. Chironi, C. M. Boulanger, A. Simon, F. Dignat-George, J. Freyssinet, and A. Tedgui, “Endothelial microparticles in diseases,” Cell and Tissue Research, vol. 335, no. 1, pp. 143–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. F. Mause and C. Weber, “Microparticles: protagonists of a novel communication network for intercellular information exchange,” Circulation Research, vol. 107, no. 9, pp. 1047–1057, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. L. L. Horstman and Y. S. Ahn, “Platelet microparticles: a wide-angle perspective,” Critical Reviews in Oncology/Hematology, vol. 30, no. 2, pp. 111–142, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. N. A. Hussein, E. W. Meesters, N. Osmanovic, F. P. H. T. M. Romijn, R. Nieuwland, and A. Sturk, “Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo,” Journal of Thrombosis and Haemostasis, vol. 1, no. 11, pp. 2434–2443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Combes, A. Simon, G. Grau et al., “In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant,” Journal of Clinical Investigation, vol. 104, no. 1, pp. 93–102, 1999. View at Scopus
  18. M. C. Martínez, A. Tesse, F. Zobairi, and R. Andriantsitohaina, “Shed membrane microparticles from circulating and vascular cells in regulating vascular function,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 3, pp. H1004–H1009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Diamant, M. E. Tushuizen, A. Sturk, and R. Nieuwland, “Cellular microparticles: new players in the field of vascular disease?” European Journal of Clinical Investigation, vol. 34, no. 6, pp. 392–401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. 2012 NHLBI Fact Book, Chapter 4, Disease Statistics: Prevalence of Common Cardiovascular and Lung Diseases, US., 2007–2011.
  21. Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases.
  22. P. E. Belchetz, “Hormonal treatment of postmenopausal women,” The New England Journal of Medicine, vol. 330, no. 15, pp. 1062–1071, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Grodstein, M. J. Stampfer, J. E. Manson et al., “Postmenopausal estrogen and progestin use and the risk of cardiovascular disease,” The New England Journal of Medicine, vol. 335, no. 7, pp. 453–461, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. Dick, D. E. DeWitt, and B. D. Anawalt, “Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia,” The American Journal of Managed Care, vol. 8, no. 1, pp. 95–104, 2002. View at Scopus
  25. S. Hulley, D. Grady, T. Bush et al., “Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women,” The Journal of the American Medical Association, vol. 280, no. 7, pp. 605–613, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. C. M. Viscoli, L. M. Brass, W. N. Kernan, P. M. Sarrel, S. Suissa, and R. I. Horwitz, “A clinical trial of estrogen-replacement therapy after ischemic stroke,” The New England Journal of Medicine, vol. 345, no. 17, pp. 1243–1249, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Simoncini, “Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging,” Climacteric, vol. 12, no. 1, pp. 6–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Morel, F. Toti, B. Hugel et al., “Procoagulant microparticles: disrupting the vascular homeostasis equation?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2594–2604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Bretelle, F. Sabatier, D. Desprez et al., “Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction,” Thrombosis and Haemostasis, vol. 89, no. 3, pp. 486–492, 2003. View at Scopus
  30. M. J. VanWijk, K. Boer, R. J. Berckmans et al., “Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents,” Thrombosis and Haemostasis, vol. 88, no. 3, pp. 415–420, 2002. View at Scopus
  31. Z. Mallat, H. Benamer, B. Hugel et al., “Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes,” Circulation, vol. 101, no. 8, pp. 841–843, 2000. View at Scopus
  32. R. A. Preston, W. Jy, J. J. Jimenez et al., “Effects of severe hypertension on endothelial and platelet microparticles,” Hypertension, vol. 41, no. 2, pp. 211–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. C. M. Boulanger, A. Scoazec, T. Ebrahimian et al., “Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction,” Circulation, vol. 104, no. 22, pp. 2649–2652, 2001. View at Scopus
  34. D. Burger and R. M. Touyz, “Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells,” Journal of the American Society of Hypertension, vol. 6, no. 2, pp. 85–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. S. Shet, O. Aras, K. Gupta et al., “Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes,” Blood, vol. 102, no. 7, pp. 2678–2683, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. L. L. Horstman, W. Jy, J. J. Jimenez, and Y. S. Ahn, “Endothelial microparticles as markers of endothelial dysfunction,” Frontiers in Bioscience, vol. 9, pp. 1118–1135, 2004. View at Scopus
  37. J. J. Jimenez, W. Jy, L. M. Mauro, C. Soderland, L. L. Horstman, and Y. S. Ahn, “Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis,” Thrombosis Research, vol. 109, no. 4, pp. 175–180, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. A. F. Tramontano, R. Lyubarova, J. Tsiakos, T. Palaia, J. R. Deleon, and L. Ragolia, “Circulating endothelial microparticles in diabetes mellitus,” Mediators of Inflammation, vol. 2010, Article ID 250476, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. H. van Ierssel, E. M. van Craenenbroeck, V. M. Conraads et al., “Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied,” Thrombosis Research, vol. 125, no. 4, pp. 332–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Yong, C. H. Koh, and W. Shim, “Endothelial microparticles: missing link in endothelial dysfunction?” European Journal of Preventive Cardiology, vol. 20, no. 3, pp. 496–512, 2013. View at Publisher · View at Google Scholar
  41. J. Huber, A. Vales, G. Mitulovic et al., “Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 1, pp. 101–107, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland, “Microparticles in cardiovascular diseases,” Cardiovascular Research, vol. 59, no. 2, pp. 277–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. N. MacKman and G. E. Davis, “Blood coagulation and blood vessel development: is tissue factor the missing link?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2364–2366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Rautou, A. S. Leroyer, B. Ramkhelawon et al., “Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration,” Circulation Research, vol. 108, no. 3, pp. 335–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Ludwicka-Bradley, E. Tourkina, S. Suzuki et al., “Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-γ activation,” The American Journal of Respiratory Cell and Molecular Biology, vol. 22, no. 2, pp. 235–243, 2000. View at Scopus
  46. A. M. Curtis, P. F. Wilkinson, M. Gui, T. L. Gales, E. Hu, and J. M. Edelberg, “p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles,” Journal of Thrombosis and Haemostasis, vol. 7, no. 4, pp. 701–709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. D. B. Peterson, T. Sander, S. Kaul et al., “Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles,” Proteomics, vol. 8, no. 12, pp. 2430–2446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Franchini, “Hemostasis and aging,” Critical Reviews in Oncology/Hematology, vol. 60, no. 2, pp. 144–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. G. A. Zimmerman, “Thinking small, but with big league consequences: procoagulant microparticles in the alveolar space,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 297, no. 6, pp. L1033–L1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. S. V. Brodsky, K. Malinowski, M. Golightly, J. Jesty, and M. S. Goligorsky, “Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential,” Circulation, vol. 106, no. 18, pp. 2372–2378, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. J. P. Rerolle, A. Hertig, G. Nguyen, J. D. Sraer, and E. P. Rondeau, “Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis,” Kidney International, vol. 58, no. 5, pp. 1841–1850, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Philippova, Y. Suter, S. Toggweiler et al., “T-cadherin is present on endothelial microparticles and is elevated in plasma in early atherosclerosis,” European Heart Journal, vol. 32, no. 6, pp. 760–771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Krupiczojc, C. J. Scotton, and R. C. Chambers, “Coagulation signalling following tissue injury: focus on the role of factor Xa,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 6-7, pp. 1228–1237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. R. C. Chambers, “Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?” The British Journal of Pharmacology, vol. 153, supplement 1, pp. S367–S378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Ludwicka-Bradley, G. Bogatkevich, and R. M. Silver, “Thrombin-mediated cellular events in pulmonary fibrosis associated with systemic sclerosis (scleroderma),” Clinical and Experimental Rheumatology, vol. 22, no. 3, supplement 33, pp. S38–S46, 2004. View at Scopus
  56. B. G. Bachhuber, I. J. Sarembock, L. W. Gimple, and G. K. Owens, “α-thrombin induces transforming growth factor-β1 mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor,” Journal of Vascular Research, vol. 34, no. 1, pp. 41–48, 1997. View at Scopus
  57. A. Ludwicka-Bradley, R. M. Silver, and G. S. Bogatkevich, “Coagulation and autoimmunity in scleroderma interstitial lung disease,” Seminars in Arthritis and Rheumatism, vol. 41, no. 2, pp. 212–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Sapet, S. Simoncini, B. Loriod et al., “Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2,” Blood, vol. 108, no. 6, pp. 1868–1876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Simoncini, M. Njock, S. Robert et al., “Trail/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation,” Circulation Research, vol. 104, no. 8, pp. 943–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Ueba, T. Haze, M. Sugiyama et al., “Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome,” Thrombosis and Haemostasis, vol. 100, no. 2, pp. 280–285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Takeya, E. C. Gabazza, S. Aoki, H. Ueno, and K. Suzuki, “Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells,” Blood, vol. 102, no. 5, pp. 1693–1700, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. M. C. Martinez and R. Andriantsitohaina, “Microparticles in angiogenesis: therapeutic potential,” Circulation Research, vol. 109, no. 1, pp. 110–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Obinata and T. Hla, “Sphingosine 1-phosphate in coagulation and inflammation,” Seminars in Immunopathology, vol. 34, no. 1, pp. 73–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Markiewicz, S. S. Nakerakanti, B. Kapanadze, A. Ghatnekar, and M. Trojanowska, “Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells,” Microcirculation, vol. 18, no. 1, pp. 1–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. W. Jy, J. J. Jimenez, L. M. Mauro et al., “Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation,” Journal of Thrombosis and Haemostasis, vol. 3, no. 6, pp. 1301–1308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Sabatier, V. Roux, F. Anfosso, L. Camoin, J. Sampol, and F. Dignat-George, “Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity,” Blood, vol. 99, no. 11, pp. 3962–3970, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Jy, A. Minagar, J. J. Jimenez et al., “Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis,” Frontiers in Bioscience, vol. 9, pp. 3137–3144, 2004. View at Scopus
  68. M. Cesari, M. Pahor, and R. A. Incalzi, “Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions,” Cardiovascular Therapeutics, vol. 28, no. 5, pp. e72–e91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. C. J. Epstein, G. M. Martin, A. L. Schultz, and A. G. Motulsky, “Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process,” Medicine, vol. 45, no. 3, pp. 177–221, 1966. View at Scopus
  70. R. Lacroix and F. Dignat-George, “Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation,” Thrombosis Research, vol. 129, supplement 2, pp. S27–S29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Q. van Veen, J. C. M. Meijers, M. Levi, T. M. van Gulik, and M. A. Boermeester, “Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis,” Shock, vol. 27, no. 5, pp. 534–541, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. F. Tita-Nwa, A. Bos, A. Adjei, W. B. Ershler, D. L. Longo, and L. Ferrucci, “Correlates of D-dimer in older persons,” Aging—Clinical and Experimental Research, vol. 22, no. 1, pp. 20–23, 2010. View at Scopus
  73. Y. Song, H. Shen, D. Schenten, P. Shan, P. J. Lee, and D. R. Goldstein, “Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 1, pp. 103–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Folkman and Y. Shing, “Angiogenesis,” The Journal of Biological Chemistry, vol. 267, no. 16, pp. 10931–10934, 1992. View at Scopus
  75. V. Djonov, M. Schmid, S. A. Tschanz, and P. H. Burri, “Intussusceptive angiogenesis. Its role in embryonic vascular network formation,” Circulation Research, vol. 86, no. 3, pp. 286–292, 2000. View at Scopus
  76. J. Li, Y. Zhang, and R. S. Kirsner, “Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix,” Microscopy Research and Technique, vol. 60, no. 1, pp. 107–114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. S. V. Brodsky, F. Zhang, A. Nasjletti, and M. S. Goligorsky, “Endothelium-derived microparticles impair endothelial function in vitro,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 286, no. 5, pp. H1910–H1915, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. P. J. Mateos-Caceres, J. J. Zamorano-Leon, P. Rodriguez-Sierra, C. Macaya, and A. J. Lopez-Farre, “New and old mechanisms associated with hypertension in the elderly,” International Journal of Hypertension, vol. 2012, Article ID 150107, 10 pages, 2012. View at Publisher · View at Google Scholar
  79. K. H. Jung, K. Chu, S. T. Lee et al., “Circulating endothelial microparticles as a marker of cerebrovascular disease,” Annals of Neurology, vol. 66, no. 2, pp. 191–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Mezentsev, R. M. H. Merks, E. O'Riordan et al., “Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 3, pp. H1106–H1114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Davizon and J. A. López, “Microparticles and thrombotic disease,” Current Opinion in Hematology, vol. 16, no. 5, pp. 334–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. V. L. T. Ballard and J. M. Edelberg, “Targets for regulating angiogenesis in the ageing endothelium,” Expert Opinion on Therapeutic Targets, vol. 11, no. 11, pp. 1385–1399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. P. E. Gates, W. D. Strain, and A. C. Shore, “Human endothelial function and microvascular ageing,” Experimental Physiology, vol. 94, no. 3, pp. 311–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Burger, D. G. Kwart, A. C. Montezano et al., “Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence,” Journal of the American Heart Association, vol. 1, no. 3, Article ID e001842, 2012.
  85. N. Amabile, P. Rautou, A. Tedgui, and C. M. Boulanger, “Microparticles: key protagonists in cardiovascular disorders,” Seminars in Thrombosis and Hemostasis, vol. 36, no. 8, pp. 907–916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. Z. Mallat, B. Hugel, J. Ohan, G. Lesèche, J. Freyssinet, and A. Tedgui, “Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity,” Circulation, vol. 99, no. 3, pp. 348–353, 1999. View at Scopus
  87. R. Lacroix, F. Sabatier, A. Mialhe et al., “Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro,” Blood, vol. 110, no. 7, pp. 2432–2439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. M. A. Thomashow, D. Shimbo, M. A. Parikh et al., “Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The multiethnic study of atherosclerosis chronic obstructive pulmonary disease study,” The American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 1, pp. 60–68, 2013. View at Publisher · View at Google Scholar
  89. J. M. Edelberg and M. J. Reed, “Aging and angiogenesis,” Frontiers in Bioscience, vol. 8, pp. s1199–s1209, 2003. View at Scopus
  90. J. M. Hill, G. Zalos, J. P. J. Halcox et al., “Circulating endothelial progenitor cells, vascular function, and cardiovascular risk,” The New England Journal of Medicine, vol. 348, no. 7, pp. 593–600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Heiss, S. Keymel, U. Niesler, J. Ziemann, M. Kelm, and C. Kalka, “Impaired progenitor cell activity in age-related endothelial dysfunction,” Journal of the American College of Cardiology, vol. 45, no. 9, pp. 1441–1448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Markiewicz, Y. Asano, S. Znoyko, Y. Gong, D. K. Watson, and M. Trojanowska, “Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skin,” Journal of Dermatological Science, vol. 47, no. 3, pp. 217–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Koike, R. B. Vernon, M. D. Gooden, E. Sadoun, and M. J. Reed, “Inhibited angiogenesis in aging: a role for TIMP-2,” Journals of Gerontology A, vol. 58, no. 9, pp. 798–805, 2003. View at Scopus
  94. C. N. Bagot, M. S. Marsh, M. Whitehead et al., “The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy,” Journal of Thrombosis and Haemostasis, vol. 8, no. 8, pp. 1736–1744, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. D. E. Morales, K. A. McGowan, D. S. Grant et al., “Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model,” Circulation, vol. 91, no. 3, pp. 755–763, 1995. View at Scopus
  96. H. W. Schnaper, K. A. McGowan, S. Kim-Schulze, and M. C. Cid, “oestrogen and endothelial cell angiogenic activity,” Clinical and Experimental Pharmacology and Physiology, vol. 23, no. 3, pp. 247–250, 1996. View at Scopus
  97. C. D. Venkov, A. B. Rankin, and D. E. Vaughan, “Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function,” Circulation, vol. 94, no. 4, pp. 727–733, 1996. View at Scopus
  98. S. Kim-Schulze, K. A. McGowan, S. C. Hubchak et al., “Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells,” Circulation, vol. 94, no. 6, pp. 1402–1407, 1996. View at Scopus
  99. X. Jin, Y. C. Chen, W. Q. Liu, H. Y. Wang, B. Wang, and Z. Zeng, “Estradiol promote myocardial anglogenesis in a rat model of acute myocardial infarction through estrogen receptors,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 39, no. 3, pp. 398–401, 2008. View at Scopus
  100. K. L. Hamilton, L. Lin, Y. Wang, and A. A. Knowlton, “Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression,” Physiological Genomics, vol. 32, no. 2, pp. 254–263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. A. S. Pechenino, L. Lin, F. N. Mbai et al., “Impact of aging versus estrogen loss on cardiac gene expression: estrogen replacement and inflammation,” Physiological Genomics, vol. 43, no. 18, pp. 1065–1073, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. A. A. Knowlton and A. R. Lee, “Estrogen and the cardiovascular system,” Pharmacology and Therapeutics, vol. 135, no. 1, pp. 54–70, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Gopal, S. Garibaldi, L. Goglia et al., “Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1),” Molecular Human Reproduction, vol. 18, no. 8, pp. 410–416, 2012. View at Publisher · View at Google Scholar
  104. D. W. Losordo and J. M. Isner, “Estrogen and angiogenesis: a review,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 1, pp. 6–12, 2001. View at Scopus
  105. R. R. Greb, O. Heikinheimo, R. F. Williams, G. D. Hodgen, and A. L. Goodman, “Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesterone-receptor ligands in vivo,” Human Reproduction, vol. 12, no. 6, pp. 1280–1292, 1997. View at Scopus
  106. M. Rusnati, G. Casarotti, S. Pecorelli, G. Ragnotti, and M. Presta, “Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometrium,” Gynecologic Oncology, vol. 48, no. 1, pp. 88–93, 1993. View at Publisher · View at Google Scholar · View at Scopus
  107. M. C. Cid, H. K. Kleinman, D. S. Grant, H. W. Schnaper, A. S. Fauci, and G. S. Hoffman, “Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1,” Journal of Clinical Investigation, vol. 93, no. 1, pp. 17–25, 1994. View at Scopus
  108. M. C. Cid, H. W. Schnaper, and H. K. Kleinman, “Estrogens and the vascular endothelium,” Annals of the New York Academy of Sciences, vol. 966, pp. 143–157, 2002. View at Scopus
  109. M. J. Reed and J. M. Edelberg, “Impaired angiogenesis in the aged,” Science of Aging Knowledge Environment, vol. 2004, no. 7, p. pe7, 2004. View at Scopus
  110. M. Jayachandran, R. D. Litwiller, W. G. Owen, and V. M. Miller, “Circulating microparticles and endogenous estrogen in newly menopausal women,” Climacteric, vol. 12, no. 2, pp. 177–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Rank, R. Nieuwland, K. Nikolajek et al., “Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women,” Archives of Gynecology and Obstetrics, vol. 285, no. 4, pp. 1035–1041, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Forest, E. Pautas, P. Ray et al., “Circulating microparticles and procoagulant activity in elderly patients,” Journals of Gerontology A, vol. 65, no. 4, pp. 414–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. J. Simak, M. P. Gelderman, H. Yu, V. Wright, and A. E. Baird, “Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome,” Journal of Thrombosis and Haemostasis, vol. 4, no. 6, pp. 1296–1302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. J. B. Williams, E. C. Jauch, C. J. Lindsell, and B. Campos, “Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis,” Academic Emergency Medicine, vol. 14, no. 8, pp. 685–690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. L. Carcaillon, M. Alhenc-Gelas, Y. Bejot et al., “Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the three-city cohort study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1445–1451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. T. Hoekstra, J. M. Geleijnse, C. Kluft, E. J. Giltay, F. J. Kok, and E. G. Schouten, “4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly,” Stroke, vol. 34, no. 12, pp. 2822–2828, 2003. View at Publisher · View at Google Scholar · View at Scopus
  117. H. M. Björck, P. Eriksson, U. Alehagen et al., “Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure,” The American Journal of Hypertension, vol. 24, no. 7, pp. 802–808, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. E. Steogonekpień, E. Stankiewicz, J. Zalewski, J. Godlewski, K. zmudka, and I. Wybrańska, “Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation,” Archives of Medical Research, vol. 43, no. 1, pp. 31–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Sinning, J. Losch, K. Walenta, M. Böhm, G. Nickenig, and N. Werner, “Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes,” European Heart Journal, vol. 32, no. 16, pp. 2034–2041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. N. Amabile, C. Heiss, W. M. Real et al., “Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension,” The American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 11, pp. 1268–1275, 2008. View at Publisher · View at Google Scholar · View at Scopus